New Laser-Like device aims to ease glaucoma without drops

NCT ID NCT05999006

Completed Disease control Sponsor: Elios Vision, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a device called the ELIOS System to safely lower eye pressure in adults with mild to moderate open-angle glaucoma. The procedure is done alone, without other surgeries, and aims to reduce pressure by at least 20% while possibly using fewer medications. Researchers are checking how well it works and if it is safe for patients.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ELIOS System (device)
What this could lead to: If successful, this could offer a new, less invasive procedure to control eye pressure in glaucoma patients, potentially reducing reliance on daily eye drops.
What could go wrong: This is an early feasibility study with only 22 participants, so results may not apply to all glaucoma patients. The procedure may not lower pressure enough or could have unexpected side effects.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLAUCOMA, PRIMARY OPEN ANGLE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

open-angle glaucoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GLAUCOMA, PRIMARY OPEN ANGLE

Contacts and locations

Locations

Elios Vision Clinical Site

Glendale, Arizona, 85306, United States
Elios Vision Clinical Site

Rock Island, Illinois, 61201, United States
Elios Vision Clinical Site

St Louis, Missouri, 63108, United States
Elios Vision Clinical Site

Oklahoma City, Oklahoma, 73112, United States
Elios Vision Clinical Site

El Paso, Texas, 79902, United States
Elios Vision Clinical Site

Kenosha, Wisconsin, 53142, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.